secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2023-11-27T23:59:59+00:00
Accession:  0001193125-23-283346
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio appoints Moses Makunje as Principal Accounting Officer and Principal Financial Officer
--------------------------------------------------------------------------------

- Appointment effective Nov 27, 2023; Makunje previously VP Finance since Jan 2022.
- Annual base salary of $343,873; eligible for discretionary incentive bonus with 35% target.
- CPA with over 16 years experience including at Ernst & Young and Maze Therapeutics.
- No family relationships with directors or other officers; no material transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312523283346/0001193125-23-283346-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312523283346/d831512d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-283346

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer